Molecular virology in transfusion medicine laboratory.
作者信息
Candotti Daniel, Allain Jean-Pierre
机构信息
National Health Service Blood and Transplant, Cambridge, UK.
出版信息
Blood Transfus. 2013 Apr;11(2):203-16. doi: 10.2450/2012.0219-12. Epub 2012 Dec 21.
Abstract
摘要
相似文献
1
Molecular virology in transfusion medicine laboratory.输血医学实验室中的分子病毒学
Blood Transfus. 2013 Apr;11(2):203-16. doi: 10.2450/2012.0219-12. Epub 2012 Dec 21.
2
Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.针对病毒 DNA/RNA 的红细胞和全血病原体失活：发展中国家的设计、技术和未来前景。
Blood Transfus. 2017 Oct;15(6):512-521. doi: 10.2450/2017.0344-16. Epub 2017 Apr 13.
3
Development of working reagents and international standards.工作试剂和国际标准的开发。
Biologicals. 1998 Jun;26(2):115-7. doi: 10.1006/biol.1998.0135.
4
Blood donations: justifying blood donor restrictions.献血：论证献血者限制的合理性。
Br J Haematol. 2016 Sep;174(5):822-3. doi: 10.1111/bjh.13811. Epub 2015 Oct 22.
5
[Technological evolutions in blood donation screening and their impact on the residual risk].[献血筛查的技术演变及其对残余风险的影响]
Transfus Clin Biol. 2011 Apr;18(2):292-301. doi: 10.1016/j.tracli.2011.02.025. Epub 2011 Apr 3.
6
Genomic screening for blood-borne viruses in transfusion settings.输血环境中血源性病原体的基因组筛查。
Vox Sang. 1998;74 Suppl 2:119-23. doi: 10.1111/j.1423-0410.1998.tb05408.x.
7
[Prevention of transfusion-associated viral infection].[输血相关病毒感染的预防]
Rinsho Byori. 2003 Feb;Suppl 124:121-6.
8
[Viral safety measures of plasma for transfusion and applicability in Spain].[用于输血的血浆的病毒安全措施及其在西班牙的适用性]
Med Clin (Barc). 2007 Oct 6;129(12):458-68. doi: 10.1157/13111004.
9
[Molecular biology in medicine. IX. In situ hybridization].[医学中的分子生物学。IX. 原位杂交]
Rev Invest Clin. 1997 May-Jun;49(3):255-8.
10
[Ten years of nucleic acid testing: lessons and prospects].[十年核酸检测：经验与展望]
Transfus Clin Biol. 2011 Apr;18(2):133-9. doi: 10.1016/j.tracli.2011.01.007. Epub 2011 Mar 11.
引用本文的文献
1
Assessment of Hepatitis E virus transmission risks: a comprehensive review of cases among blood transfusion recipients and blood donors.戊型肝炎病毒传播风险评估：对输血受者和献血者中病例的全面综述
Infect Ecol Epidemiol. 2024 Oct 15;14(1):2406834. doi: 10.1080/20008686.2024.2406834. eCollection 2024.
2
Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?乙肝病毒血液筛查：是否需要重新评估血液安全措施？
Front Med (Lausanne). 2018 Feb 21;5:29. doi: 10.3389/fmed.2018.00029. eCollection 2018.
3
Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.输血医学中的隐匿性肝炎感染：筛查策略及抗-HBc检测当前应用情况评估
Transfus Med Hemother. 2017 Aug;44(4):263-272. doi: 10.1159/000460301. Epub 2017 May 5.
4
Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.中国南方抗-HBc 阳性合格献血者隐匿性乙型肝炎病毒感染的特征及随访研究。
Blood Transfus. 2017 Jan;15(1):6-12. doi: 10.2450/2016.0268-15. Epub 2016 May 17.
5
Occult hepatitis B virus infection and blood transfusion.隐匿性乙型肝炎病毒感染与输血
World J Hepatol. 2015 Mar 27;7(3):600-6. doi: 10.4254/wjh.v7.i3.600.
6
Current testing strategies for hepatitis C virus infection in blood donors and the way forward.献血者丙型肝炎病毒感染的现行检测策略及未来发展方向。
World J Gastroenterol. 2014 Mar 21;20(11):2948-54. doi: 10.3748/wjg.v20.i11.2948.
7
Into the occult: strategies for preventing transfusion-transmissible infections.深入探讨隐匿问题：预防输血传播感染的策略
Indian J Gastroenterol. 2013 Sep;32(5):289-90. doi: 10.1007/s12664-013-0344-z. Epub 2013 Jul 20.
本文引用的文献
1
Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity.在自身免疫和药物诱导毒性的误导背景下发生的输血传播性戊型肝炎。
J Hepatol. 2012 Dec;57(6):1374-8. doi: 10.1016/j.jhep.2012.08.001. Epub 2012 Aug 8.
2
Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity.黎巴嫩献血者中乙型肝炎病毒 DNA 剪接与基因型 A 至 E 株：对乙型肝炎病毒 DNA 定量和传染性的影响。
J Clin Microbiol. 2012 Oct;50(10):3159-67. doi: 10.1128/JCM.01251-12. Epub 2012 Jul 11.
3
Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?血液供应中的人细小病毒4以及混合血浆源性凝血因子的传播：这有关系吗？
Transfusion. 2012 Jul;52(7):1398-403. doi: 10.1111/j.1537-2995.2012.03721.x.
4
Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa.加纳（西非的一个地方性流行区）的人疱疹病毒 8 经输血传播。
Transfusion. 2012 Nov;52(11):2294-9. doi: 10.1111/j.1537-2995.2012.03607.x. Epub 2012 Mar 15.
5
Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.美国献血者中新获得和流行的 HIV、乙型肝炎病毒和丙型肝炎病毒感染的遗传多样性。
J Infect Dis. 2012 Mar 15;205(6):875-85. doi: 10.1093/infdis/jir862. Epub 2012 Jan 31.
6
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.东南亚献血者隐匿性乙型肝炎感染：分子特征及发生的潜在机制。
Gut. 2012 Dec;61(12):1744-53. doi: 10.1136/gutjnl-2011-301281. Epub 2012 Jan 20.
7
Transfusion-transmitted hepatitis E: is screening warranted?输血传播的戊型肝炎：是否需要进行筛查？
Indian J Med Microbiol. 2011 Oct-Dec;29(4):353-8. doi: 10.4103/0255-0857.90158.
8
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.由输血感染的新生儿向其母亲发生乙型肝炎病毒（HBV）的逆向垂直传播。
J Hepatol. 2012 Mar;56(3):734-7. doi: 10.1016/j.jhep.2011.07.034. Epub 2011 Oct 23.
9
Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.南非 4 年个体供者核酸检测期间输血传播乙型肝炎病毒：估计和观察到的窗口期风险。
Transfusion. 2012 Apr;52(4):880-92. doi: 10.1111/j.1537-2995.2011.03355.x. Epub 2011 Oct 7.
10
Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.输血传播感染监测：五个发达国家系统比较。
Transfus Med Rev. 2012 Jan;26(1):38-57. doi: 10.1016/j.tmrv.2011.07.001. Epub 2011 Sep 25.
Zotero 插件